About this trial
This pilot study will evaluate the safety and 1-year erectile function recovery in 10 patients undergoing a novel Nerve Restoring Radical Cystectomy (NR-RC), which includes a genitofemoral nerve graft. Erectile function will be assessed using IIEF-5, SF-MPQ, and CEEF questionnaires at baseline and at multiple post-operative intervals (4 weeks, 3, 6, 12, and 18 months). Safety will be monitored through peri- and post-operative complications, and additional demographic and clinical data will be collected for analysis.
Eligibility criteria
Qualifiers
Patients undergoing standard of care radical cystectomy for bladder cancer
Patients must have preoperative erectile function with a baseline IIEF score of ≥17
Disqualifiers
Patients with previous pelvic surgery
Patients with previous pelvic radiotherapy
Patients aged < 18 years at diagnosis
Legally incapable patients
Trial design
Treatments tested in this trial
- Patients undergoing radical cystectomy will receive a novel NR-RC procedure using a genitofemoral nerve graft to enhance erectile function recovery.